NCT05095662

Establish a Specific Cohort Database for Depressive Disorders

Shanghai Mental Health Center·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Depressive Disorder
Study type
Observational
Sponsor & location
Primary sponsor
Shanghai Mental Health Center
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2021
End date
Dec 31, 2026
Enrollment
80000 participants
Primary outcome

Construct the structured data set for depression by integrating a large sample of outpatient and inpatient clinical data, blood tests, psychological tests, and brain imaging data.

Summary

Depression is characterized by high prevalence, high recurrence rate, high disability rate,
 high suicide rate, and heavy disease burden. However, the diagnosis, treatment, and prognosis
 of depression are difficult to meet the clinical needs at present. This study plans to
 integrate a large sample of hospital clinical data, laboratory examination data, brain
 imaging, and electrophysiological data, as well as audio-visual data, to establish a database
 for depressive disorder, and long-term follow-up to form a specific disease cohort. This
 study will provide a scientific basis for exploring biomarkers related to objective diagnosis
 and treatment of depression.

ICD-10 classifications
Depressive conduct disorderRecurrent depressive disorder, unspecifiedRecurrent depressive disorderOther recurrent depressive disordersRecurrent depressive disorder, currently in remission
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05095662
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05095662 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Mental Health Center and is currently Not yet recruiting. The study focuses on Depressive Disorder. Target enrollment is 80000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.